BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection
Status: | Completed |
---|---|
Conditions: | Infectious Disease, HIV / AIDS |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 16 - Any |
Updated: | 4/21/2016 |
Start Date: | June 2006 |
End Date: | January 2007 |
Biojector 2000 Open-Label Safety Study (BOSS) to Evaluate Signs and Symptoms Associated With a Needle-free Injection Device for Administration of Fuzeon to Patients With HIV-1 Infection
This study will evaluate the signs and symptoms associated with Fuzeon injection (90mg sc)
using the B2000 needle-free injection device, in HIV-1 positive patients experienced to
Fuzeon treatment, but having difficulty tolerating long-term (>4 weeks) administration of
Fuzeon with the standard needle and syringe. Patients will be randomized to the B2000 device
or the standard needle and syringe for 4 weeks; all patients will use the B2000 device for
the next 4 weeks. The anticipated time on study treatment is <3 months, and the target
sample size is 100-500 individuals.
using the B2000 needle-free injection device, in HIV-1 positive patients experienced to
Fuzeon treatment, but having difficulty tolerating long-term (>4 weeks) administration of
Fuzeon with the standard needle and syringe. Patients will be randomized to the B2000 device
or the standard needle and syringe for 4 weeks; all patients will use the B2000 device for
the next 4 weeks. The anticipated time on study treatment is <3 months, and the target
sample size is 100-500 individuals.
Inclusion Criteria:
- adult patients >=16 years of age;
- current or former Fuzeon user who may benefit from needle-free administration of
Fuzeon;
- naive to use of the B2000 device;
- positive test results for human immunodeficiency virus infection.
Exclusion Criteria:
- patients naive to Fuzeon;
- inability to self-inject Fuzeon, or no reliable caregiver to administer injections;
- evidence of active, untreated, opportunistic infections.
We found this trial at
39
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials